-
461por Vo, Quynh T, Onofrey, Shauna, Church, Daniel, Cranston, Kevin, DeMaria, Alfred, Klevens, R Monina“…OBJECTIVES: To characterize hepatitis C testing in Massachusetts and guide stakeholders in addressing the needs of people living with hepatitis C. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
462por Papatheodoridis, George V., Goulis, John, Sypsa, Vana, Lionis, Christos, Manolakopoulos, Spilios, Elefsiniotis, Ioannis, Anagnostou, Olga, Tsoulas, Christos, Hatzakis, Angelos, Dalekos, George N.“…In July 2017, the Hellenic National Plan for Hepatitis C was announced in alignment with the World Health Organization goals for the eradication of hepatitis C virus (HCV) by the year 2030. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
463por Klein, Marina BEnlace del recurso
Publicado 2019
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
464“…The treatment of chronic hepatitis C has been revolutionized with the introduction of direct-acting antivirals (DAAs). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
465“…Hepatitis C virus (HCV) is a major cause of liver cirrhosis and hepatocellular carcinoma. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
466“…AIM OF THE STUDY: According to the World Health Organization (WHO) strategy, elimination of hepatitis C virus (HCV) as a major public health threat by 2030 includes diagnosis and cure of 90% of those infected between 2015 and 2030. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
467por Mohamed, Rosmawati, Shabaruddin, Fatiha H, Azzeri, Amirah, McDonald, Scott A, Dahlui, MaznahEnlace del recurso
Publicado 2019
Enlace del recurso
Online Artículo Texto -
468por Zarębska-Michaluk, Dorota“…Successful antiviral treatment for hepatitis C virus (HCV) infection is crucial to prevent progression of the disease and its most serious complications. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
469por Constancio, Natasha Silva, Ferraz, Maria Lucia Gomes, Martins, Carmen Tzanno Branco, Kraychete, Angiolina Campos, Bitencourt, Paulo Lisboa, do Nascimento, Marcelo Mazza“…According to data from the last census of the Brazilian Society of Nephrology (SBN), the prevalence of hepatitis C virus (HCV) in Brazilian hemodialysis units (HU) is 3.3%, about three times higher than what is reported for the Brazilian general population. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
470por Fukuhara, Takasuke, Tani, Hideki, Shiokawa, Mai, Goto, Yukinori, Abe, Takayuki, Taketomi, Akinobu, Shirabe, Ken, Maehara, Yoshihiko, Matsuura, Yoshiharu“…Interestingly, the PIDR-mediated entry of HCVser and HCVcc was enhanced by the addition of sera from chronic hepatitis C patients but not from healthy donors. In addition, neutralization of HCVcc infection by anti-E2 antibody was canceled by the treatment with PIDR. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
471“…Hepatitis C virus (HCV) infections constitute a major public health problem and are the main cause of chronic hepatitis and liver disease worldwide. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
472
-
473por Wade, Amanda JEnlace del recurso
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
474“…The narrow range of species permissive to infection by hepatitis C virus (HCV) presents a unique challenge to the development of useful animal models for studying HCV, as well as host immune responses and development of chronic infection and disease. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
475por Jhaveri, Ravi“…In March and April of 2020, public health authorities issued major updates to screening recommendations for hepatitis C virus infection. With the rise in cases driven by injection drug use coupled with access to highly effective therapies promising a cure, all adults aged ≥18 years should receive one-time hepatitis C virus antibody screening in any health care setting. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
476por Devi, SharmilaEnlace del recurso
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
477por Hasan, Fuad, Alfadhli, Ahmad, Al-Gharabally, Abeer, Alkhaldi, Mahmoud, Colombo, Massimo, Lazarus, Jeffrey V“…The hepatitis C virus (HCV) is estimated to affect 71 million people worldwide. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
478“…A functional adaptive immune response is the major determinant for clearance of hepatitis C virus (HCV) infection. However, in the majority of patients, this response fails and persistent infection evolves. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
479“…Rice were rewarded with Nobel Prize in Physiology or Medicine for “the discovery of hepatitis C virus (HCV)”. During the past 50 years, remarkable achievements have been made in treatment of HCV infection: it has changed from being a life-threatening chronic disease to being curable. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
480por Yim, Hyung JoonEnlace del recurso
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto